Seeking Alpha

ChinaMart » Comments » WX

  • China Biotech Week in Review: Earnings, Deals and Drug Development [View article]
    LTUS (Lotus Pharmaceuticals) reaffirmed 2008 guidance on Friday. That guidance of $13.8M USD in net income is about .29/share fully diluted...making the PE for LTUS well under 4.
    As far as I can tell, this makes LTUS the best value in the China Biopharma sector today.
    Jun 02 07:14 am |Rating: 0 0 |Link to Comment
  • WuXi Pharmatech Reports Another Healthy Quarter [View article]
    A forward PE of 26? Might want to check out LTUS.OB (Lotus Pharmaceuticals) with a forward PE of UNDER 3 based on 2008 make good of $13.8M net income, or about .29/share.
    May 29 08:35 am |Rating: 0 0 |Link to Comment
More on WX by ChinaMart
Comments by Ticker
ChinaMart's
Comments Stats
30 comments
Rating: 0 (0 - 0 )